{"transactions":[{"id":675235,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-26T20:00:03.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":16201,"price":51.0576,"value":827184.1776,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.91 to $51.39 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":195862,"source":{"system":"sec-edgar","filing":"0001193125-26-368244","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000119312526368244/ownership.xml","form_type":"4"}},{"id":675234,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-26T20:00:03.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":20799,"price":50.3111,"value":1046420.5689,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.90 to $50.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":212063,"source":{"system":"sec-edgar","filing":"0001193125-26-368244","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000119312526368244/ownership.xml","form_type":"4"}},{"id":675233,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-26T20:00:03.000Z","date":"2026-08-24","kind":"sale","planned":true,"acquired":false,"shares":13160,"price":49.9983,"value":657977.628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.90 to $50.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":232862,"source":{"system":"sec-edgar","filing":"0001193125-26-368244","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000119312526368244/ownership.xml","form_type":"4"}},{"id":680222,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:09:03.000Z","date":"2026-08-19","kind":"sale","planned":true,"acquired":false,"shares":404,"price":49.9,"value":20159.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025."}],"balance_after":246022,"source":{"system":"sec-edgar","filing":"0001193125-26-359189","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000119312526359189/ownership.xml","form_type":"4"}},{"id":803828,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-21T20:55:07.000Z","date":"2026-04-17","kind":"sale","planned":true,"acquired":false,"shares":20225,"price":39.9923,"value":808844.2675,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.90 to $40.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":246426,"source":{"system":"sec-edgar","filing":"0001193125-26-167091","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000119312526167091/ownership.xml","form_type":"4"}},{"id":808956,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-14T20:13:40.000Z","date":"2026-04-14","kind":"sale","planned":true,"acquired":false,"shares":10200,"price":35.0781,"value":357796.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.90 to $35.37 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":266651,"source":{"system":"sec-edgar","filing":"0001193125-26-154908","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000119312526154908/ownership.xml","form_type":"4"}},{"id":808955,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-14T20:13:40.000Z","date":"2026-04-13","kind":"sale","planned":true,"acquired":false,"shares":9165,"price":34.974,"value":320536.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.90 to $35.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":276851,"source":{"system":"sec-edgar","filing":"0001193125-26-154908","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000119312526154908/ownership.xml","form_type":"4"}},{"id":808954,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-14T20:13:40.000Z","date":"2026-04-10","kind":"sale","planned":true,"acquired":false,"shares":500,"price":34.98,"value":17490.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025."}],"balance_after":286016,"source":{"system":"sec-edgar","filing":"0001193125-26-154908","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000119312526154908/ownership.xml","form_type":"4"}},{"id":811670,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-04-09T20:30:27.000Z","date":"2026-04-08","kind":"sale","planned":true,"acquired":false,"shares":360,"price":34.9,"value":12564.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025."}],"balance_after":286516,"source":{"system":"sec-edgar","filing":"0001193125-26-149725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000119312526149725/ownership.xml","form_type":"4"}},{"id":827496,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-03-26T20:41:16.000Z","date":"2026-03-25","kind":"sale","planned":true,"acquired":false,"shares":10115,"price":29.9906,"value":303354.919,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.90 to $30.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":286876,"source":{"system":"sec-edgar","filing":"0001193125-26-126410","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000119312526126410/ownership.xml","form_type":"4"}},{"id":919699,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T21:11:22.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":120000,"derivative":{"exercise_price":27.75,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001193125-26-037581","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000119312526037581/ownership.xml","form_type":"4"}},{"id":952205,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:19:48.000Z","date":"2025-12-31","kind":"sale","planned":false,"acquired":false,"shares":2840,"price":30.05,"value":85342.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person."}],"balance_after":296991,"source":{"system":"sec-edgar","filing":"0001193125-26-002469","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000119312526002469/ownership.xml","form_type":"4"}},{"id":952204,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:19:48.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":9000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 4, 2024, the Reporting Person was granted performance-based restricted stock units (\"PSUs\") subject to the satisfaction of specified performance criteria as of December 31, 2025. The issuers Compensation Committee confirmed that the performance criteria had been met, resulting in the vesting of such PSUs effective December 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 4, 2024, the Reporting Person was granted performance-based restricted stock units (\"PSUs\") subject to the satisfaction of specified performance criteria as of December 31, 2025. The issuers Compensation Committee confirmed that the performance criteria had been met, resulting in the vesting of such PSUs effective December 31, 2025."}],"balance_after":299831,"source":{"system":"sec-edgar","filing":"0001193125-26-002469","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000119312526002469/ownership.xml","form_type":"4"}},{"id":1285322,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T22:30:07.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":110000,"derivative":{"exercise_price":16.6,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0000950170-25-013753","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000095017025013753/ownership.xml","form_type":"4"}},{"id":1485300,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":19581,"kind":"person","name":"Yeleswaram Krishnaswamy","position":1,"cik":"0002022156","reported_name":"Yeleswaram Krishnaswamy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T23:42:12.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":84904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on June 6, 2025, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":84904,"derivative":{"exercise_price":17,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":84904},"source":{"system":"sec-edgar","filing":"0000950170-24-071538","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022156/000095017024071538/ownership.xml","form_type":"4"}}]}